Blood Pressure after Treatment with Sodium ‐Glucose Cotransporter 2 Inhibitors Influences Renal Composite Outcome: Analysis using Propensity Score Matched Models

ConclusionIn Japanese type 2 diabetes mellitus patients with chronic kidney disease, blood pressure after SGLT2i administration influences the renal composite outcome. Blood pressure management is important even during treatment with SGLT2i.

Source: Journal of Diabetes Investigation - June 6, 2020 Category: Endocrinology Authors: Kazuo Kobayashi, Masao Toyoda, Nobuo Hatori, Takayuki Furuki, Hiroyuki Sakai, Tomoya Umezono, Shun Ito, Daisuke Suzuki, Hiroshi Takeda, Fuyuki Minagawa, Hisakazu Degawa, Hareaki Yamamoto, Hideo Machimura, Keiichi Chin, Toshimasa Hishiki, Ma Tags: ORIGINAL ARTICLE Source Type: research